In addition, compared with modern western medicine, such as GLP-1R agonists have the risk of nausea, diarrhea, vomiting, constipation and pancreatitis (Liu et al., 2022), while XMT has the characteristics of multi-component, multi-target and less adverse reactions. Here, GLP1R is linked to pancreatitis.